SYK STRYKER CORPORATION

Stryker names Nick Mead Vice President, Investor Relations

Stryker names Nick Mead Vice President, Investor Relations

Jason Beach appointed Vice President, Group CFO, MedSurg and Neurotechnology

Portage, Michigan, March 31, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today Nick Mead has been appointed Vice President, Investor Relations, effective May 1, 2026.

Mead has nearly 20 years of experience at Stryker, with leadership roles spanning multiple divisions and business units across the company. Most recently, he served as Vice President, Finance for Stryker’s Medical division, where he partnered closely with senior leaders to support commercial strategy, capital allocation and operational execution.

“Nick brings deep institutional knowledge, strong financial expertise and a proven ability to support strategic decision making across the organization,” said Preston Wells, Vice President, Chief Financial Officer, Stryker. “His broad experience across our businesses and his strong relationships with internal and external stakeholders position him well to lead our investor relations function as we continue to execute our strategy and deliver value for shareholders.”

Since joining Stryker, Mead has held a variety of roles across the finance organization, supporting businesses within Endoscopy, Medical and Neurotechnology, Orthopaedics and Spine. Throughout his career, he has played a key role in commercial planning, investment decisions and mergers and acquisitions, supporting growth across implants, capital and service portfolios.

Jason Beach, Vice President, Finance and Investor Relations, has been named Vice President, Group Chief Financial Officer, MedSurg and Neurotechnology. Beach joined Stryker in 2018, serving as Vice President, Finance for Stryker’s Instruments division, where he supported strong business performance and led multiple acquisitions and finance transformation initiatives. He is a proven finance leader, recognized for his strong operational leadership, strategic insight and collaborative approach.

About Stryker

Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at .

Contacts

For investor inquiries:

Jason Beach, Vice President, Finance and Investor Relations at 269-385-2600 or

For media inquiries:

Kim Montagnino, Vice President, Chief Communications Officer at 269-385-2600 or



EN
31/03/2026

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on STRYKER CORPORATION

 PRESS RELEASE

Stryker names Nick Mead Vice President, Investor Relations

Stryker names Nick Mead Vice President, Investor Relations Jason Beach appointed Vice President, Group CFO, MedSurg and Neurotechnology Portage, Michigan, March 31, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today Nick Mead has been appointed Vice President, Investor Relations, effective May 1, 2026. Mead has nearly 20 years of experience at Stryker, with leadership roles spanning multiple divisions and business units across the company. Most recently, he served as Vice President, Finance for Stryker’s Medical division, where he p...

 PRESS RELEASE

Stryker announces Annual Meeting of Shareholders

Stryker announces Annual Meeting of Shareholders Portage, Michigan, March 23, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced its 2026 Annual Meeting of Shareholders is scheduled as follows: Wednesday, May 6, 2026 – 12:00 p.m. Eastern Time The Meeting will be held virtually via the internet. Information about the webcast, which will include both the audio and the slide presentation from the meeting, is available on the Investor Relations page of our website at . A recording of the annual meeting will also be available from 10:30 a.m., Eastern Time, on Thursday, May 7, 2026 at u...

Stryker Corporation: Cyberattack on Stryker is contained, with prolong...

Stryker appears well positioned to absorb the operational and financial effects of the recent cyber incident.

Stryker Corporation - December 2025 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Stryker Corp: 1 director

A director at Stryker Corp sold 500,000 shares at 363.439USD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch